October 28, 2021 10:54 AM EDTUpdated 11:17 AM
Coronavirus
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Biden pumps $500M in­to do­mes­tic test­ing pro­duc­tion; Val­ne­va mulls pro­duc­tion deal

Josh Sullivan

The US De­part­ment of Health and Hu­man Ser­vices has in­vest­ed an ad­di­tion­al $562 mil­lion in US com­pa­nies to boost the do­mes­tic man­u­fac­tur­ing of Covid-19 tests …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times